bremelanotide; dopamine; sexual dysfunction

INTRODUCTION AND OBJECTIVE Bremelanotide is FDA approved for premenopausal women with generalized, acquired hypoactive sexual desire disorder (HSDD). It modulates dopaminergic pathways involved in sexual desire and arousal in men and women and has been reported to increase genital blood flow...